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Abstract
Background: The present work summarizes the research activities on radiation-induced late effects in the rat spinal
cord carried out within the “clinical research group ion beam therapy” funded by the German Research Foundation
(DFG, KFO 214).
Methods and materials: Dose–response curves for the endpoint radiation-induced myelopathy were determined
at 6 different positions (LET 16–99 keV/μm) within a 6 cm spread-out Bragg peak using either 1, 2 or 6 fractions of
carbon ions. Based on the tolerance dose TD50 of carbon ions and photons, the relative biological effectiveness
(RBE) was determined and compared with predictions of the local effect model (LEM I and IV). Within a longitudinal
magnetic resonance imaging (MRI)-based study the temporal development of radiation-induced changes in the
spinal cord was characterized. To test the protective potential of the ACE (angiotensin converting enzyme)-inhibitor
ramipril™, an additional dose–response experiment was performed.
Results: The RBE-values increased with LET and the increase was found to be larger for smaller fractional doses.
Benchmarking the RBE-values as predicted by LEM I and LEM IV with the measured data revealed that LEM IV is
more accurate in the high-LET, while LEM I is more accurate in the low-LET region. Characterization of the temporal
development of radiation-induced changes with MRI demonstrated a shorter latency time for carbon ions, reflected
on the histological level by an increased vessel perforation after carbon ion as compared to photon irradiations. For
the ACE-inhibitor ramipril™, a mitigative rather than protective effect was found.
Conclusions: This comprehensive study established a large and consistent RBE data base for late effects in the rat
spinal cord after carbon ion irradiation which will be further extended in ongoing studies. Using MRI, an extensive
characterization of the temporal development of radiation-induced alterations was obtained. The reduced latency
time for carbon ions is expected to originate from a dynamic interaction of various complex pathological processes.
A dominant observation after carbon ion irradiation was an increase in vessel perforation preferentially in the white
matter. To enable a targeted pharmacological intervention more details of the molecular pathways, responsible for
the development of radiation-induced myelopathy are required.
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Background
Carbon ion therapy is increasingly applied in patients with
skull base tumors [1, 2]. Although the clinical outcome is
quite promising [3–5], a major limitation originates from
the limited knowledge of the tolerance doses for late nor-
mal tissue reactions in the central nervous system (CNS),
which mainly originates from the increased relative bio-
logical effectiveness (RBE) of carbon ions as compared to
photons. As a result, radiation doses to the tumor and
normal tissue are assessed in terms of RBE-weighted
rather than absorbed dose [6]. The RBE, however, is a
complex quantity and depends critically on the linear
energy transfer (LET), on the fractional dose as well as on
biological parameters and the considered biological end-
point. In clinical practice, the RBE is predicted quantita-
tively by biophysical models, such as the local effect
model (LEM) [7], and this prediction includes significant
uncertainties. Besides clinical investigations, experimental
studies in animals have been performed to validate these
RBE-models and to depict differences in the development
of late CNS reactions between high- and low-LET
irradiations.
The RBE of carbon ions in the rat spinal cord was
evaluated for the endpoint radiation-induced myelopathy
in previous studies [8–11], however, only one data set
examined the dependence of the RBE on dose and LET
[8, 9]. In those dose–response studies, irradiations of the
spinal cord were performed in the entrance region and
in the middle of a 1 cm spread-out Bragg peak (SOBP)
using different fractionation schemes. Comparison of the
results with predictions of the clinically used LEM I
showed a significant underestimation of the RBE in the
SOBP and deviations in the functional dependence on
dose in the entrance region. These findings gave rise to
further developments and resulted in the more recent
version LEM IV [12], which is, however, not yet applied
in patients. Since these early studies only covered two
extreme LET-conditions, a systematic in vivo evaluation
of the accuracy of the two model versions was not pos-
sible. Furthermore, although some early histological
investigations to decipher radiation-induced myelopathy
after carbon ion irradiation exist [13], no systematic
studies on the temporal development and no correlation
with findings in clinically relevant imaging modalities,
such as magnetic resonance imaging (MRI), is presently
available.
Within the translationally oriented clinical research
group KFO 214 on heavy ion therapy, funded by the
German Research Foundation (DFG), the radiation
response of the rat spinal cord was extensively investi-
gated. This contribution gives a brief summary of previ-
ously published data [14–16] in terms of dose–response
curves for the endpoint radiation-induced myelopathy.
Additionally, preliminary results of project-related,
unpublished studies are presented including an MRI-
and histology-based study to examine the temporal de-
velopment of myelopathy. To protect the spinal cord
from radiation-induced damage, the impact of an ACE-
(angiotensin-converting-enzyme) inhibitor was tested.
Methods and materials
Animals and anesthesia
For the described studies, a total of 597 young adult fe-
male Sprague–Dawley (SD) rats (Charles River, Sulzfeld,
Germany) were used. Animals were kept under standard
conditions at the German Cancer Research Center
(DKFZ) animal laboratory facility. For irradiations, rats
received gaseous anesthesia with a mixture of 4% Sevo-
flurane (Abbott, Wiesbaden, Germany) and 2 l/min oxy-
gen, whereas for the MRI-measurements 2.5 Vol%
Isoflurane (Abbott, Wiesbaden, Germany) in 1.5 l/min oxy-
gen was used. All experiments were approved by the gov-
ernmental review committee on animal care (35–9185.81/
G62–08, G117/13, G34/13).
Follow-up and biological endpoint
After irradiation, animals were monitored once a week
for general health condition and weight. Paresis grade II
is defined as neurological symptoms by regular dragging
of the foot with palmar flexion or dragging of extended
foreleg [17]. A preliminary stage is paresis grade I mean-
ing that the rat shows obvious neurological detractions
but the animal is still able to use its forelegs.
The biological endpoint was defined as “radiation-in-
duced myelopathy (paresis grade II) within 300 days”.
Animals showing this endpoint were scored as re-
sponder, sacrificed and the spinal cord was processed for
histological examinations.
Dose–response studies
Details of the experimental setup has been described pre-
viously [14] and only a brief summary is given here. The
rat cervical spinal cord (segments C1–6, field size 10 × 15
mm2) was irradiated at 6 different positions (35, 65, 80,
100, 120 and 127 mm) of a 6 cm spread-out Bragg peak
(SOBP, range 70–130 mm water-equivalent depth) corre-
sponding to a dose-averaged linear energy transfer (LET)
of 16–99 keV/μm. The range of the ions was adjusted
using appropriate polymethyl-methacrylate (PMMA)-boli
placed in front of the animals. Irradiations were performed
in groups of 5 animals with increasing dose levels using
either 1 or 2 fractions (Fx) to cover 0–100% response
probability. Animal numbers were selected to determine
TD50 (dose at 50% probability of paresis grade II) with a
standard error of about 0.5 Gy. Irradiations were per-
formed under identical conditions either at the Helmholtz
Center for Heavy Ion Research (GSI, 100 mm mid-
position), or (after beam time became available) at the
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Heidelberg Heavy Ion Therapy Center (HIT, all other po-
sitions) using the active raster scanning technique [18].
The presented results for 1 and 2 Fx included a total of
464 irradiated rats as well as 10 sham treated controls.
For each fractionation schedule and each position of
the spinal cord within the SOBP, a dose–response curve
was determined by performing a maximum-likelihood fit
of the logistic dose–response model to the actuarial
response rates (technical details, see [14, 15]). Based on
the TD50-values of photons [8, 9] and carbon ions, the
RBE was calculated. The experimental RBE was com-
pared to model predictions using the version I and IV of
local effect model (LEM) [7, 12]. RBE-calculations with
the LEM were performed with the treatment planning
system TRiP (Treatment Planning for Particles [19]) for
the experimentally obtained TD50-values.
MRI-based longitudinal study
To investigate the temporal development of radiation-
induced myelopathy, 24 irradiated animals and 7 sham-
treated controls were included in an MR-based longitudinal
study. Irradiated animals received 6 Fx of either carbon ions
(center of 1 cm SOBP; LET: 91 keV/μm (range, 80–
104 keV/μm)) or 6 MV photons using approximately isoef-
fective total doses of 23 Gy (RBE) or 61 Gy, respectively.
Based on our previous study [8], these doses were known
to cause radiation-induced myelopathy in all animals.
For imaging, a 1.5 T MRI scanner (Symphony, Siemens,
Erlangen) in combination with an in-house made radio-
frequency coil was used. To record the initial state, rats
were imaged prior to irradiation. After irradiation, rats
were monitored monthly and as soon as morphological
alterations in the MR-images occurred, the measurement
intervals were reduced.
MRI measurements included a T2-weighted sequence
(TE 109 ms, TR 4000 ms, FOV 40 mm) to detect edema.
To prove the onset of a blood-spinal cord barrier (BSCB)
disruption a T1-weighted sequence (TE 14 ms, TR
600 ms, FOV 46 mm) in combination with contrast agent
application (0.2 mmol/kg, Magnevist®, Bayer, Leverkusen)
was used. In addition, a T1-weighted dynamic contrast-
enhanced (DCE) MR sequence (TE 1.75 ms, TR 373 ms,
FOV 150 mm) was used to study radiation-induced alter-
ations in blood perfusion. DCE-measurements were evalu-
ated using a pharmacokinetic model [20, 21] allowing the
determination of the relative plasma volume, vp, the rela-
tive interstitial volume, ve and the volume transfer coeffi-
cient Ktrans.
Histology
Animals reaching the endpoint paresis grade II were per-
fused with a mixture of 4% paraformaldehyde (PFA) in
0.015 M phosphate buffered saline. The cervical spinal
cord C1–6 was dissected out and postfixed overnight.
Cryosections of 8 μm thickness were used for a general
staining with hemalum/eosin (HE) in combination with
Luxol fast blue [22]. Luxol fast blue was used to examine
qualitatively the extent of demyelination since the dye
attaches to the lipoproteins of the myelin. A reduced
signal is assigned with affected areas.
To study the degree of blood vessel perforation, ex-
travasated serum albumin was immunohistochemically
visualized. For this, paraffin sections of 8 μm thickness
were deparaffinized and rehydrated. Endogenous perox-
idase activity was blocked with 3% H2O2. To unmask
antigen sites, an antigen retrieval with sodium citrate
buffer (pH 6) was performed. Sections were then incu-
bated overnight at 4 °C with the primary antibody
against albumin (Acris, 1:6000 diluted in 3% bovine
serum albumin) followed by incubation with the second-
ary antibody (Abcam, 1:500, horse raddish peroxidase).
3,3′-diaminobenzidine was used as chromogen. After-
wards the sections were counterstained with Nissl and
evaluated by light microscopy.
Radioprotectiva study
The protective influence of the ACE-inhibitor ramipril™
was investigated in a four-armed dose–response experi-
ment using a total of 88 animals and four sham-treated
controls. Animals were irradiated with single doses of car-
bon ions (center of 6 cm SOBP; LET: 45 keV/μm) or 6
MV photons. 4 animals per dose group with increasing
dose levels were used to cover 0–100% response probabil-
ity. Each modality includes an experimental arm with and
without ramipril™ administration. The ACE-inhibitor was
given immediately after irradiation (2 mg/kg/day) via their
drinking water (ad libitum) during the full observation
time of 300 days.
Results
The irradiation procedure, MRI follow-up and ACE-
inhibitor intake was well tolerated by all animals. Rats
which had to be excluded during follow-up due to spon-
taneous development of mammary carcinomas or death
due to unknown reasons were considered by an actuarial
approach.
Dose–response studies
Figure 1 summarizes the dose–response curves obtained
at the 6 positions within the SOBP after one and two
fractions of carbon ions. The corresponding TD50-values
decreased significantly with increasing LET and in-
creased with increasing fraction number, i.e. decreasing
fractional dose. Figure 2 displays the resulting LET-
dependence of the RBE after single and split doses. It
was found that the RBE increases much stronger after 2
fractions than after single fractions. Comparing the mea-
sured RBE-values with predictions of the LEM revealed
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that LEM IV better predicts this stronger increase, and
in general provides a much better description in the
high-LET region (30–100 keV/μm) of the SOBP while
LEM I is more accurate in the low-LET region
(~20 keV/μm) of the plateau.
MRI-based longitudinal study
MRI measurements after carbon ion and photon irradi-
ation revealed the same morphological alterations in the
MR images ranging from the development of edema, syr-
inx (dilatation of the canalis centralis) and contrast agent
accumulation up to the final development of the
radiation-induced myelopathy (Fig. 3). The latency time
until development of paresis grade II, however, was signifi-
cantly shorter for carbon ions (136 ± 10 d) than for pho-
tons (211 ± 20 d). Evaluation of the DCE-measurements
exhibited a continuous increase of the parameters ve and
Ktrans with increasing damage of the BSCB, however, no
significant differences between carbon ion and photon
irradiation was found, except for the shorter latency time.
No significant changes were found for the parameter vp.
Histology
After carbon ion as well as after photon irradiation
histological examinations of the endpoint paresis grade
II revealed a comparable extent of tissue damage (Fig. 4).
Compared to the unirradiated control, a structural de-
cline in terms of white matter vacuolization, necrosis,
blood vessel dilatation and disruption was found in the
posterior and lateral part for both radiation modalities.
A clear demyelination represented by the loss of luxol
fast blue staining has been seen after photon irradiation
(Fig. 4c). The blood vessels in the grey matter were
dilated and perforated whereas the overall structure
remained visually intact. However, a larger extent of
blood vessel perforation was found after carbon ion than
after photon irradiation. The albumin extravasation, rep-
resented by a brown precipitation, was more intense
after carbon ion irradiation, predominately in the dorsal
part of the white matter and around the canalis centralis
whereas after photon irradiation the albumin extravasa-
tion was found to be weaker in these areas (Fig. 4).
Radioprotectiva study
No protective effect of ramipril™ for the development of
radiation-induced myelopathy after carbon ion or pho-
ton irradiations was observed. However, a modality and
dose dependent prolongation of latency time of 23 ± 8 d
after carbon ion irradiation and 16 ± 3 d after photon ir-
radiation was found.
Discussion
Only very few studies on late effects in normal tissue are
presently available [11, 13, 23, 24]. Radiation-induced
Fig. 1 Dose–response curves for the endpoint paresis grade II after
irradiation of the spinal cord with either single (a) or split (b) doses of
carbon ions or photons at 6 different positions within a 6 cm SOBP
Fig. 2 RBE-dependence on LET for single and split doses. In addition,
RBE-values predicted by LEM I and LEM IV are displayed
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myelopathy is a feared late side effect in the CNS, char-
acterized by a long symptom-free latency period
followed by a sudden occurrence of neurological symp-
toms. To prevent the development of these severe com-
plications, specific tolerance doses have to be respected
and due to the uncertainty in the knowledge of the RBE,
this is associated with significantly larger uncertainties
for carbon ions than for photons.
To investigate the accuracy of RBE-predictions by the
LEM, a large-scale dose–response study in the rat spinal
cord has been performed. This animal model is well
established for the investigation of late effects in the
Fig. 3 Representative MR-images for the biological endpoint paresis grade II after carbon ion (12C–ion) and photon irradiation compared to an
untreated control. The symptomatic animals show an edema (white arrowheads) and canalis centralis dilatation (red arrowhead) in the T2-weighted
images as well as contrast agent (CA) accumulation in the T1-weighted images (lowest row, white asterisks)
Fig. 4 Histological sections representative for the biological endpoint paresis grade II. Cryosections stained with hemalum/eosin in combination
with Luxol fast blue (a-c). A clear structural decline in the white matter represented by necrosis (asterisk) and vacuolization (open arrows) as well
as hemorrhages (white arrows) and dilated blood vessels (closed black arrows) can be seen (b, c). Paraffin sections for detection of albumin
extravasation (brown precipitation) combined with Nissl staining (d-f). Albumin leaks predominately in the area where structural decline of
white matter occurs (black asterisks) and around the canalis centralis (white arrow heads). The leakage is more intense after carbon ion (e) than photon
irradiation (f) (scale bar 200 μm)
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CNS and has been previously used to study the effective-
ness of different beam modalities [25–30]. Especially, it
has been shown that the response of the spinal cord is
independent of the irradiated volume for field lengths
above 8 mm [31, 32]. The model is also well-suited to
study the temporal development of radiation-induced
myelopathy in MRI as well as on the histological level.
This study currently presents the largest and most sys-
tematic data base.
Dose–response studies
The rat spinal cord was used to characterize the RBE-
variation along the central axis of a 6 cm SOBP for differ-
ent fractionation schedules. The details of these studies
have been published previously [14–16]. Detailed in vivo
testing of the RBE-predictions of LEM I and IV as a func-
tion of LET and fractional dose revealed that the RBE in
the high-LET region is better described by LEM IV while
the predictions of LEM I are more accurate in the low-
LET region. It has to be noted, however, that this result
refers to relatively high fractional doses. An additional
dose–response study with 6 Fx is currently under evalu-
ation and will allow to extend the benchmarking of the
LEM also towards lower doses per fraction. Together with
the presented results, this study will allow to estimate the
α/β-value, which represents the extent of tissue regener-
ation in fractionated treatments. Preliminary results based
on the single and split dose studies suggest an increase of
α/β with increasing LET, indicating a decreasing impact of
fractionation for increasing LET. For a more reliable esti-
mation, however, the 6 Fx study has to be included. It has
to be emphasized that the benchmarking of RBE-models
is not restricted to the LEM. Currently, tests are extended
to the Microdosimetric Kinetic Model (MKM) which is
used for carbon ion therapy at National Institute of Radio-
logical Science (NIRS, [33, 34]).
MRI-based longitudinal study
The MRI-based longitudinal study enables a non-invasive
investigation of occurring radiation-induced effects during
the symptom free latency time. We found a fixed
sequence of alterations in the images. Comparing the car-
bon ion and photon irradiations at isoeffective doses with
respect to the endpoint paresis grade II, the same mor-
phological changes were found and the only difference
was a shorter latency time after carbon ion irradiation.
Main findings in MRI were presence of edema, syrinx, up-
take of contrast agent due to the break-down of the BSCB
and finally followed by paresis grade I and II. Once the
edema occurred in an animal, it developed the determinis-
tic sequence. These findings were also confirmed quanti-
tatively by evaluation of the DCE-measurements, which
showed that the increase of the extracellular volume, ve,
and the contrast agent exchange rate, Ktrans, increased
similarly for carbon ions and photons.
It appears likely that the shorter latency time after car-
bon ion irradiations originates from differential actions
on the histological or molecular level and apparently,
MRI at 1.5 T is not sensitive enough for the detection of
such alterations. With respect to sensitivity, the small
diameter of the rat spinal cord and the consequently oc-
curring partial volume effects may also play a role. Using
an MRI with higher field strength would in principle be
an option to increase the sensitivity, yet, in the present
study, this was logistically not possible due to the exces-
sive number of measurements, which had to be per-
formed on a short term notice during the period where
neurological symptoms appear within a rapid time
sequence.
Despite of these limitations, this study provides the
first extensive temporal characterization of the develop-
ment of radiation-induced myelopathy after irradiation
with carbon ions and photons in MRI and in an ongoing
MRI-based histological study, tissue samples at different
time points after irradiation as well as at the occurrence
of the different endpoints in MRI are acquired. By inves-
tigating these samples on the histological and molecular
level, more detailed information on the underlying
mechanistic processes is expected.
Molecular mechanisms and inhibition
Currently, it is not clear in detail whether the target
structures of irradiation in the spinal cord are the neu-
rons or the blood vessels. Therefore, many attempts have
been made to evaluate the effects of ionizing radiation to
the neuronal [22, 35–37] and the vascular proportion
[11, 24, 38–41] supporting nowadays the view that endo-
thelial cells are the main target structure [42–44].
At the endpoint paresis grade II, histological examina-
tions revealed a comparable breakdown of the tissue
structure for both radiation modalities; however, the in-
crease of blood vessel permeability was much higher
after carbon ion irradiation. This finding is in contrast to
results of the DCE evaluation, where no difference was
seen at the same endpoint.
It has to be noted, however, that increased permeabil-
ity of the BSCB was detected with albumin, which pre-
sents a much larger molecule than MRI contrast agent
Gd-DTPA (66 vs. 0.5 kDa). The discrepancy between the
results of MRI and histological analysis could therefore
be explained by a different extent of perforation for the
two irradiation modalities. While the higher ionization
density of carbon ions introduces more complex, non-
reparable DNA-damage, which leads to intense blood
vessel perforation and thus to an increased permeability
for Gd-DTPA as well as for albumin, photons exhibit a
low ionization density which induces better reparable
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DNA-damage and leads only to small vessel perforations
and thus to an increased permeability for Gd-DTPA but
much less for albumin. To clarify this, additional histo-
logical investigations with smaller molecular markers are
required.
Besides vascular changes, also a profound damage of
the neuronal structures was observed. Luxol fast blue
staining shows a clear decrease of the myelin basic pro-
tein at the biological endpoint paresis grade II. To assess
the relative importance of vascular and neuronal dam-
age, a detailed investigation of the temporal development
of both structures on the histological and molecular
level will be performed within the ongoing MRI-based
histological study.
Detailed knowledge of the mechanistic processes may
enable targeted pharmacological interventions with the
aim of protecting the normal central nervous system tis-
sue after irradiation. First attempts along this direction
have already been described in the literature [45–48]
using ACE-inhibitors. Within a pilot trial, we used the
ACE-inhibitor ramipril™ to test the impact on radiation-
induced myelopathy after carbon ion and photon irradi-
ation. The rationale for using this drug are manifold:
ramipril™ has been shown to exhibit mitigative proper-
ties on optic neuropathy [47, 49]. In addition, with
regard to the central nervous system, the drug is able to
cross the blood-spinal cord barrier [50], does not reveal
protective effects on tumors [51] and is already used to
treat hypertension in patients. Our results showed that
myelopathy could not be prevented, however a pro-
longation of latency time was achieved, which indicates
that ramipril™ has a mitigative effect in the rat spinal
cord. Identification of the underlying pathological path-
ways leading to radiation-induced side effects would
facilitate the application of appropriate protective drugs
and, if successfully realized, could allow elevating the
tumor dose without harming the surrounding normal
tissue.
Conclusion
Within this study, a large data base on RBE for late
effects in CNS tissue of the rat after carbon ion irradi-
ation was established and used for benchmarking the
functional dependencies of the RBE on LET and dose as
predicted by LEM I and LEM IV. According to this
comparison, LEM IV better describes the measured data
in the high-LET region while LEM I predictions are
more accurate in the low-LET region. Ongoing studies
will extend this database further. Using MRI, an exten-
sive characterization of the temporal development of
radiation-induced alterations in the rat spinal cord was
obtained. The main result was a shorter latency time for
carbon ions than for photons. This finding is expected
to originate from complex pathological pathways on the
molecular level, which needs further investigations. This
hypothesis is supported by histological investigations,
where an increased vessel perforation, associated with a
differential pattern of permeability, was found after car-
bon ion as compared to photon irradiations. For the
ACE-inhibitor ramipril™, a mitigative rather than pro-
tective effect was found, however, the design of targeted
protective drugs requires more detailed knowledge on
the molecular pathways during the pathogenesis of
radiation-induced myelopathy.
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